Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
Condition: Plasma Cell Leukemia Intervention: Drug: Daratumumab Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chemotherapy | Leukemia | Research | Stem Cell Therapy | Stem Cells | Study | Transplants